Mandate

Vinge has assisted Cavotec SA in a directed new share issue

September 12, 2014

Vinge has asssited Cavotec SA in a directed new share issue to Bure Equity AB. The new issue consists of 7,138,780 new shares, corresponding to approx. 9.9% of the total number of shares outstanding in Cavotec, and will provide Cavotec with net proceeds of approx. SEK 187 million.

The Vinge team included Jesper Schönbeck and Joakim Hagberg.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025